Legal & General Group
FUSN

Legal & General Group’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Legal & General Group’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-38,101
Closed -$812K – 3558
2024
Q1 		$812K Buy
+38,101
New +$456K ﹤0.01% 2260
2020
Q3 		– Sell
-1,000
Closed -$18K – 3449
2020
Q2 		$18K Buy
+1,000
New +$17.4K ﹤0.01% 3117

Legal & General Group's FUSN Position: Q2 2024 in Review

Legal & General Group sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 38,101 shares — an estimated $812K sold.

Legal & General Group first reported a position in FUSN in Q2 2020 and held it in 2 quarters. The position peaked at $812K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

  • Legal & General Group reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 38,101 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $812K.
  • Legal & General Group first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 2 quarters.
  • Legal & General Group's Fusion Pharmaceuticals Inc. Common Shares position peaked at $812K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.